Newsroom
Find the latest information about our products
Kinase Logistics Europe News
-
Offers
Discount on Kinases from Carna Biosciences!
Read moreJoin us in celebrating another successful year with high-quality human Kinases from Carna Biosciences!
-
General
Meet us at the 11th RSC/SCI Symposium on Kinase Inhibitor Design!
Read more -
General
Next-generation Mobility Shift Assay Detection System!
Read moreWe have great News for you: MSA is still accessible to your drug discovery research!
-
General
Biotinylated Kinases
Read moreWe’ve new products for you: biologically biotinylated human Kinases from Carna Biosciences.
-
Offers
New Cellular CDK Assay Panel Launched and Special Offers from Carna
Read moreWe are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.
… -
General
New Website Launch!
Read moreWe’re extremely pleased to announce the launch of our new website!
We decided that it was time for a fresh new look, which surely empowers our…
Carna Biosciences Newsletter
-
Newsletter
Cancer treatments using inhibitors of CDK, a cell cycle regulator
Read moreCarna Newsletter Vol.16
-
Newsletter
ALK drug resistant mutations: Challenges for the treatment of lung cancer
Read moreCarna Newsletter Vol.15
-
Technical Note
DGKα and DGKζ are key targets for cancer immunotherapy
Read moreCarna Newsletter Vol.14
-
Newsletter
The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS)
Read moreCarna Newsletter Vol.13
-
Newsletter
The importance of understanding the activity of compounds on RAF dimerization in BRAF inhibitor drug discovery
Read moreCarna Biosciences Newsletter Vol. 12
-
Newsletter
Kinase Inhibitors as Potential Therapeutic Agents for COVID-19
Read moreCarna Biosciences Newsletter Vol. 11
-
Technical Note
Evaluating Kinase Inhibitors in Binding Assays using Activated and Non-Activated Biotinylated Kinases
Read moreCarna Biosciences Technical Note No. 1
-
Newsletter
Targeted Degradation of Non-catalytic Kinases New Drug Discovery Options
Read moreCarna Biosciences Newsletter Vol. 10
-
Newsletter
Drug-resistant EGFR mutations in lung cancer
Read moreCarna Biosciences Newsletter Vol. 9
-
Newsletter
Kinetic analysis of covalent and irreversible inhibitors
Read moreCarna Biosciences Newsletter Vol. 8
-
Technical Note
The importance of assessing intrinsic target kinase activity
Read moreCarna Biosciences Technical Note No. 2
-
Technical Note
Production of Highly Active Protein Kinases for Drug Discovery Applications
Read moreCarna Biosciences Technical Note No. 1
-
Newsletter
Kinase Inhibitors in the Fight against COVID-19
Read moreCarna Biosciences Newsletter Vol. 7
-
Newsletter
Recommendations for off-target profiling
Read moreCarna Biosciences Newsletter Vol. 6
-
Newsletter
The significance of ATP concentration in cell-free and cell-based assays
Read moreCarna Biosciences Newsletter Vol. 4
-
Newsletter
Targeted Protein Degraders
Read moreCarna Biosciences Newsletter Vol. 3
-
Newsletter
Residence time and compound selectivity
Read moreCarna Biosciences Newsletter Vol. 2
-
Newsletter
A story about biotin-avidin affinity and how it accelerates small molecule drug discovery
Read moreCarna Biosciences Newsletter Vol. 1